Investing.com - Vaccinex reported on Monday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Vaccinex announced earnings per share of $-0.110 on revenue of $50K. Analysts polled by Investing.com EPS of $-0.270 on revenue of $0.00.
Vaccinex 's are down 67% and is trading at $0.600 , still down 73.68% from its 52 week high of $2.28 set on Thursday, February 10, 2022.
Vaccinex shares lost 0.02% to trade at $0.600 in intra-day trade the report.
Vaccinex follows other major Healthcare sector earnings this month
Vaccinex's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar